These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 27879559)

  • 41. Vasoactive Agent Use in Septic Shock: Beyond First-Line Recommendations.
    Sacha GL; Bauer SR; Lat I
    Pharmacotherapy; 2019 Mar; 39(3):369-381. PubMed ID: 30644586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha-2 agonists to reduce vasopressor requirements in septic shock?
    Pichot C; Géloën A; Ghignone M; Quintin L
    Med Hypotheses; 2010 Dec; 75(6):652-6. PubMed ID: 20817367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of angiotensin II in treatment of refractory distributive shock.
    Rodriguez R; Fernandez EM
    Am J Health Syst Pharm; 2019 Jan; 76(2):101-107. PubMed ID: 31361800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advances in perioperative anesthetic management update on the role of vasopressin and its effects on outcomes.
    Udeh CI; Diaz-Gómez JL; Anthony D; Satyapriya A; Perez-Protto S; Hata JS
    Curr Pharm Des; 2012; 18(38):6308-13. PubMed ID: 22762470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of hypotension in septic shock.
    Whiteley SM; Dade JP
    Lancet; 1996 Mar; 347(9001):622. PubMed ID: 8596354
    [No Abstract]   [Full Text] [Related]  

  • 46. Management of Refractory Vasodilatory Shock.
    Jentzer JC; Vallabhajosyula S; Khanna AK; Chawla LS; Busse LW; Kashani KB
    Chest; 2018 Aug; 154(2):416-426. PubMed ID: 29329694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vasopressors to treat refractory septic shock.
    Meresse Z; Medam S; Mathieu C; Duclos G; Vincent JL; Leone M
    Minerva Anestesiol; 2020 May; 86(5):537-545. PubMed ID: 31994366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A plea for personalization of the hemodynamic management of septic shock.
    De Backer D; Cecconi M; Chew MS; Hajjar L; Monnet X; Ospina-Tascón GA; Ostermann M; Pinsky MR; Vincent JL
    Crit Care; 2022 Dec; 26(1):372. PubMed ID: 36457089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vasodilatory shock in the ICU and the role of angiotensin II.
    Wakefield BJ; Sacha GL; Khanna AK
    Curr Opin Crit Care; 2018 Aug; 24(4):277-285. PubMed ID: 29877879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin II in septic shock.
    Corrêa TD; Takala J; Jakob SM
    Crit Care; 2015 Mar; 19(1):98. PubMed ID: 25886853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
    Lam SW; Bauer SR; Cha SS; Oyen LJ
    Pharmacotherapy; 2008 May; 28(5):591-9. PubMed ID: 18447658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selepressin in Septic Shock.
    Antonucci E; Giovini M; Agosta S; Sakr Y; Leone M
    Shock; 2022 Jun; 57(6):172-179. PubMed ID: 35759300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regional differences in the treatment of refractory vasodilatory shock using Angiotensin II in High Output Shock (ATHOS-3) data.
    Abril MK; Khanna AK; Kroll S; McNamara C; Handisides D; Busse LW
    J Crit Care; 2019 Apr; 50():188-194. PubMed ID: 30553989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Angiotensin II in Poisoning-Induced Shock-a Review.
    Chen A; Wong A
    J Med Toxicol; 2022 Apr; 18(2):145-154. PubMed ID: 35258848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.
    Busse LW; McCurdy MT; Ali O; Hall A; Chen H; Ostermann M
    Crit Care; 2017 Dec; 21(1):324. PubMed ID: 29282149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury.
    Busse LW; Ostermann M
    Semin Nephrol; 2019 Sep; 39(5):462-472. PubMed ID: 31514910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiotensin 1-7 in an experimental septic shock model.
    Garcia B; Su F; Manicone F; Dewachter L; Favory R; Khaldi A; Moiroux-Sahroui A; Moreau A; Herpain A; Vincent JL; Creteur J; Taccone FS; Annoni F
    Crit Care; 2023 Mar; 27(1):106. PubMed ID: 36915144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Classic and Nonclassic Renin-Angiotensin Systems in the Critically Ill.
    Bitker L; Burrell LM
    Crit Care Clin; 2019 Apr; 35(2):213-227. PubMed ID: 30784605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin II in Vasodilatory Shock.
    Wakefield BJ; Busse LW; Khanna AK
    Crit Care Clin; 2019 Apr; 35(2):229-245. PubMed ID: 30784606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Should Vasopressors Be Started Early in Septic Shock?
    Cioccari L; Jakob SM; Takala J
    Semin Respir Crit Care Med; 2021 Oct; 42(5):683-688. PubMed ID: 34544185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.